nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.04.2004 | Concise Article

Persistent Colonization of Nine Cystic Fibrosis Patients with an Achromobacter (Alcaligenes) xylosoxidans Clone

verfasst von: M. Kanellopoulou, S. Pournaras, H. Iglezos, N. Skarmoutsou, E. Papafrangas, A. N. Maniatis

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2004

Einloggen, um Zugang zu erhalten

Abstract

The present study was conducted to investigate the increasing incidence of Achromobacter (previously Alcaligenes) xylosoxidans isolates being recovered from sputum samples of cystic fibrosis patients at a cystic fibrosis department for adults in Athens, Greece. During the 1-year study period, a total of 34 isolates were detected persistently in 9 of 71 cystic fibrosis patients. The isolates exhibited resistance to multiple antimicrobial agents. Isolates that were recovered repeatedly from each patient exhibited identical macrorestriction profiles with pulsed-field gel electrophoresis, indicating that the same strain persisted in the lungs of these patients. Isolates from five of the patients were genetically related, suggesting a common-source outbreak of Achromobacter xylosoxidans colonization or infection.

Yabuuchi E, Kawamura Y, Kosako Y, Ezaki T (1998) Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Ruger and Tan) comb. nov. Microbiol Immunol 42:429–438PubMed

Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF (1996) Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 23:569–576PubMed

Manfredi R, Nanetti A, Ferri M, Chiodo F (1997) Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 16:933–938PubMed

Lin YH, Liu PY, Shi ZY, Lau YJ, Hu BS (1997) Comparison of polymerase chain reaction and pulsed-field gel electrophoresis for the epidemiological typing of Alcaligenes xylosoxidans subsp. xylosoxidans in a burn unit. Diagn Microbiol Infect Dis 28:173–178CrossRefPubMed

Moissenet D, Baculard A, Valcin M, Marchand V, Tournier G, Garbarg-Chenon A et al. (1997) Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis 24:274–275PubMed

Burns JL, Emerson J, Stapp JR, et al (1998) Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27:158–163PubMed

Dunne WM Jr, Maisch S (1995) Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction. Clin Infect Dis 20:836–841PubMed

Iyobe S, Kusadokoro H, Takahashi A, et al (2002) Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans strain. Antimicrob Agents Chemother 46:2014–2016CrossRefPubMed

Riccio ML, Pallecchi L, Fontana R, Rossolini GM (2001) In70 of plasmid pAX22, a bla _VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother 45:1249–1253CrossRefPubMed

10.

Tsakris A, Pournaras S, Woodford N, et al (2000) Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 38:1290–1292PubMed

11.

Peltroche-Llacsahuanga H, Haase G, Kentrup H (1998) Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur J Clin Microbiol Infect Dis 17:132–134CrossRefPubMed

12.

Krzewinski JW, Nguyen CD, Foster JM, Burns JL (2001) Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 39:3597–3602CrossRefPubMed

13.

Fitzsimmons SC (1997) Patient registry 1996 annual data report. Cystic Fibrosis Foundation, Bethesda, MD, USA

14.

Fitzsimmons SC (1998) Patient registry 1997 annual data report. Cystic Fibrosis Foundation, Bethesda, MD, USA

15.

Tan K, Conway SP, Brownlee KG, Etherington C, Peckham DG (2002) Alcaligenes infection in cystic fibrosis. Pediatr Pulmonol 34:101–104CrossRefPubMed

16.

Saiman L, Chen Y, Tabibi S, et al (2001) Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol 39:3942–3945CrossRefPubMed

Titel: Persistent Colonization of Nine Cystic Fibrosis Patients with an Achromobacter (Alcaligenes) xylosoxidans Clone
verfasst von: M. Kanellopoulou
S. Pournaras
H. Iglezos
N. Skarmoutsou
E. Papafrangas
A. N. Maniatis
Publikationsdatum: 01.04.2004
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2004
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-004-1105-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Persistent Colonization of Nine Cystic Fibrosis Patients with an Achromobacter (Alcaligenes) xylosoxidans Clone

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2004

Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient

Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Mycobacterial Infections

Aventis Pasteur Vaccines Containing Inactivated Hepatitis A Virus: A Compilation of Immunogenicity Data

Risk Factors For Mortality In Patients With Anaerobic Bacteremia

False-Positive Results and Contamination in Nucleic Acid Amplification Assays: Suggestions for a Prevent and Destroy Strategy

African Histoplasmosis Infection with Peritoneal Involvement

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin